USPTO serial 98352409
R+ REGENOLD
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 21, 2025
- Examiner
- DIBLE, JONATHON I
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with R+ REGENOLD?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Badenweiler, DE
Badenweiler, DE
Badenweiler, DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mark P. Stone
Mark P. Stone Law Office of Mark P. Stone27 Waters EdgeChappaqua, NY 10514United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Advertising, marketing and promotion services; commercial advisory services of business nature, namely, advisory services for preparing and carrying out commercial transactions; professional business consulting, namely, strategic consultancy for commercial business transactions and regulatory submission management for assisting companies with applications for approval of pharmaceuticals, medical devices and cosmetics; administrative services in the nature of secretarial services relating to assistance with medical product approval procedures for commercial purposes; mediation and conclusion of commercial transactions for others; arranging of trade fairs for representatives from the pharmaceutical industry for commercial information and business networking purposes; business administration consultancy in the field of pharmaceutical and medical technology; import-export agency services in the fields of pharmaceutical and medical instruments and apparatus and medical devices; consultancy and information in relation to the aforesaid services. | ACTIVE | Jul 1, 2021 |
| 042 | IT services in the field of medical devices and digital healthcare, namely, software development, testing of computer software, programming of computer software for others, installation of computer software, implementation of software, and maintenance of computer software; computer software consultation in the field of medical devices and digital healthcare; advisory services relating to computer software, namely, advice on use of software in the field of digital healthcare; information technology consultancy and advice relating to installation, maintenance, and repair of computer software; information services relating to information technology architecture and infrastructure; scientific and technological consultancy, namely, development and establishment of testing procedures in the field of the digital healthcare industry; providing medical and scientific research information in the field of pharmaceutical and clinical trials; testing of medical products; product testing of computer hardware and software components of quality management systems in the field of health care; technological consultancy and information services relating to information technology architecture and infrastructure; surveying; scientific research in the nature of evaluating and analyzing technical, chemical, clinical and preclinical data for product testing and for determining conformity of the goods of others with certification standards relating to medical product approval procedures; technological consultancy services in the field of pharmaceutical and medical technology; consultancy and information in relation to the aforesaid services. | ACTIVE | Jul 1, 2021 |
| 045 | Regulatory compliance auditing; regulatory compliance consulting in the field of pharmaceuticals relating to third-party assumption of regulatory responsibilities in the healthcare and pharmaceutical industries; strategic consultancy for businesses in the nature of regulatory compliance consulting in the field of pharmaceuticals, medical devices, and cosmetics. | ACTIVE | Jul 1, 2021 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by regenold GmbH
- Other trademarks owned by regenold GmbH
- Other trademarks owned by regenold GmbH
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 045
- Similar marks named R+ REGENOLD
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 21, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 21, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 3, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 3, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 27, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 16, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 11, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 11, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 11, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 24, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 24, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 24, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 7, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| May 7, 2024 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| May 7, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 11, 2024 | NWAP | NEW APPLICATION ENTERED | — |